RAISIO TO GAIN ADDITIONAL RIGHTS TO STANOL ESTER AND BENECOL BRAND
Raisio plc, Stock Exchange Release 25 October 2007
RAISIO TO GAIN ADDITIONAL RIGHTS TO STANOL ESTER AND BENECOL BRAND
Raisio and its United States' partner, McNeil Nutritionals, LLC, and its
European partner, Cilag GmbH International, have signed an amendment to their
agreement that will return the rights to the stanol ester compound to Raisio in
the United States, Great Britain, France, Ireland, and Benelux countries. In
addition, Raisio will gain rights to the Benecol brand in France and the United
States in categories in which McNeil and Cilag are not currently active. In
return Raisio will make royalty payments and provide marketing support to McNeil
and Cilag.
Cilag will retain exclusive rights to the Benecol brand in Great Britain,
Ireland, Belgium, and Luxembourg. McNeil and Cilag will also retain rights in
the categories in which they currently hold strong positions in both France and
the United States.
Raisio aims to be an active player in the growing European, Asian and United
States markets for cholesterol-lowering functional foods by introducing
innovative product applications. Raisio's strength in different market areas is
its adaptability. This means that Benecol brand products are launched in the
market with local partners in applications matching the local consumption
habits.
RAISIO PLC
Heidi Hirvonen
Communications Manager
tel. +358 2 443 2242 or +358 50 567 3060
Further information:
Matti Rihko, CEO, tel. +358 400 830 727
Distribution:
OMX Nordic Exchange, Helsinki
Key media
www.raisio.com